BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,890,743 | -81.3% | 408,297 | -66.6% | 0.01% | -87.2% |
| Q3 2022 | $15,419,000 | +22.0% | 1,223,721 | +2.4% | 0.05% | +14.6% |
| Q2 2022 | $12,638,000 | +61.8% | 1,194,511 | -69.4% | 0.04% | -55.4% |
| Q1 2020 | $7,811,000 | +14364.8% | 3,905,676 | +35114.8% | 0.09% | – |
| Q4 2017 | $54,000 | -80.9% | 11,091 | -79.4% | 0.00% | -100.0% |
| Q3 2017 | $282,000 | -78.3% | 53,796 | -38.2% | 0.00% | -87.5% |
| Q2 2015 | $1,301,000 | – | 87,111 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |